There has been an alarming increase in the prevalence of obesity in people with type 1
diabetes in recent years. Although obesity has long been recognized as a major risk factor …

Islet autoimmunity in type 1 diabetes results in the loss of the pancreatic β-cells. The
consequences of insulin deficiency in the portal vein for liver fat are poorly understood …

Abstract Background and Aim Little is known about the diagnostic value of hepatic steatosis
index (HSI) and fatty liver index (FLI), as well as their link to metabolic syndrome in type 1 …

Objectives Zinc (Zn) deficiency often occurs in the patients with diabetes. Effects of Zn
deficiency on diabetes-induced hepatic injury were investigated. Methods Type 1 diabetes …

Patients with diabetes are at risk for liver disorders including glycogen hepatopathy, non-
alcoholic fatty liver disease, cirrhosis, and hepatic fibrosis. The pathophysiological …

High prevalence of non-alcoholic fatty liver disease (NAFLD) and very diverse outcomes that
are related to disease form and severity at presentation have made the search for …

Our previous study has shown that reduced insulin resistance (IR) was one of the possible
mechanisms for the therapeutic effect of silibinin on non-alcoholic fatty liver disease …

Over the past few decades, non-alcoholic fatty liver disease (NAFLD) has become one, if not
the most common, cause of chronic liver disease affecting both adults and children. The …

Aims Assess prevalence of hepatic steatosis (HS) and of fibrosis in an unselected
population of patients with type 1 diabetes. Describe their clinical profile and explore the …

Antioxidant therapy has been thought to be effectual for the prevention and treatment of
various diseases including diabetes. Therefore, the present study was designed to …